Market Overview The US ablation devices market is experiencing cost-effectiveness emphasis where insurance coverage, reimbursement optimization, and economic outcomes drive procedure access. The US ablation devices market is projected to exceed USD 3.2 billion through 2030, with economic emphasis driven by healthcare cost concerns, value-based care adoption, and insurance coverage...